• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies.1型西格玛受体基因与精神分裂症之间无关联:病例对照研究的分析与荟萃分析结果
BMC Psychiatry. 2003 Oct 21;3:13. doi: 10.1186/1471-244X-3-13.
2
Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis.
Schizophr Res. 2012 Nov;141(2-3):279-80. doi: 10.1016/j.schres.2012.06.043. Epub 2012 Jul 19.
3
Lack of association between sigma receptor gene variants and schizophrenia.σ受体基因变异与精神分裂症之间不存在关联。
Psychiatry Clin Neurosci. 2004 Aug;58(4):359-63. doi: 10.1111/j.1440-1819.2004.01268.x.
4
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia.
Mol Psychiatry. 2002;7(5):515-8. doi: 10.1038/sj.mp.4001029.
5
The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex.SIGMAR1 基因与精神分裂症风险和前额叶皮层激活有关。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1309-15. doi: 10.1016/j.pnpbp.2011.04.008. Epub 2011 Apr 28.
6
A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease.σ-1受体基因的一个变体是阿尔茨海默病的保护因素。
Am J Geriatr Psychiatry. 2005 Dec;13(12):1062-6. doi: 10.1176/appi.ajgp.13.12.1062.
7
Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia.1型σ受体基因多态性与精神分裂症之间的关联。
Neurosci Lett. 1998 Nov 20;257(1):45-8. doi: 10.1016/s0304-3940(98)00797-6.
8
Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study.
Am J Med Genet. 2000 Feb 7;96(1):118-22.
9
Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease.载脂蛋白 E 与 sigma-1 受体基因多态性相互作用影响阿尔茨海默病的严重程度。
Curr Alzheimer Res. 2011 Nov;8(7):765-70. doi: 10.2174/156720511797633232.
10
No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.在中国人群中,GSK - 3β基因的基因多态性与精神分裂症之间无显著关联。
J Psychiatr Res. 2008 Apr;42(5):365-70. doi: 10.1016/j.jpsychires.2007.01.005. Epub 2007 Mar 26.

引用本文的文献

1
Multi-Target Directed Ligands (MTDLs) Binding the σ Receptor as Promising Therapeutics: State of the Art and Perspectives.多靶标导向配体(MTDLs)与σ 受体结合作为有前途的治疗药物:现状与展望。
Int J Mol Sci. 2021 Jun 14;22(12):6359. doi: 10.3390/ijms22126359.
2
Sigma receptors [σRs]: biology in normal and diseased states.西格玛受体[σRs]:正常及疾病状态下的生物学特性
J Recept Signal Transduct Res. 2016 Aug;36(4):327-388. doi: 10.3109/10799893.2015.1015737. Epub 2015 Jun 9.
3
Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.神经退行性疾病和精神疾病中的西格玛-1受体伴侣蛋白
Expert Opin Ther Targets. 2014 Dec;18(12):1461-76. doi: 10.1517/14728222.2014.972939. Epub 2014 Oct 21.
4
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.靶向配体门控分子伴侣 sigma-1 受体治疗神经精神疾病。
Expert Opin Ther Targets. 2011 May;15(5):557-77. doi: 10.1517/14728222.2011.560837. Epub 2011 Mar 5.
5
The pharmacology of sigma-1 receptors.sigma-1 受体的药理学。
Pharmacol Ther. 2009 Nov;124(2):195-206. doi: 10.1016/j.pharmthera.2009.07.001. Epub 2009 Jul 18.
6
Sigma receptors: biology and therapeutic potential.西格玛受体:生物学特性与治疗潜力
Psychopharmacology (Berl). 2004 Jul;174(3):301-19. doi: 10.1007/s00213-004-1920-9. Epub 2004 Jun 10.

本文引用的文献

1
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.西格玛配体EMD 57445(帕纳美辛)及其代谢产物在急性精神分裂症中的抗精神病作用和耐受性:一项开放性临床试验
Psychiatry Res. 1999 Dec 27;89(3):275-80. doi: 10.1016/s0165-1781(99)00100-6.
2
Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study.
Am J Med Genet. 2000 Feb 7;96(1):118-22.
3
Efficacy and safety of the sigma receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial.西格玛受体配体EMD 57445(帕纳美新)治疗精神分裂症患者的疗效与安全性:一项开放性临床试验
Pharmacopsychiatry. 1999 Mar;32(2):68-72. doi: 10.1055/s-2007-979194.
4
Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia.1型σ受体基因多态性与精神分裂症之间的关联。
Neurosci Lett. 1998 Nov 20;257(1):45-8. doi: 10.1016/s0304-3940(98)00797-6.
5
Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.精神分裂症患者大脑中σ降低,但纹状体多巴胺D4位点未增加。
Eur J Pharmacol. 1996 Oct 31;314(3):R3-5. doi: 10.1016/s0014-2999(96)00702-9.
6
sigma Receptor antagonists block the development of sensitization to cocaine.σ受体拮抗剂可阻断对可卡因的致敏作用的发展。
Eur J Pharmacol. 1996 Jan 25;296(2):123-8. doi: 10.1016/0014-2999(95)00693-1.
7
[3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes.[3H]YM-09151-2(奈莫必利),一种对σ1和σ2受体亚型均有效的放射性配体。
Neuroreport. 1996 Apr 10;7(5):1057-61. doi: 10.1097/00001756-199604100-00021.
8
Efficacy and safety of an opiate sigma-receptor antagonist (SL 82.0715) in schizophrenic patients with negative symptoms: an open dose-range study.阿片类σ受体拮抗剂(SL 82.0715)治疗阴性症状精神分裂症患者的疗效与安全性:一项开放剂量范围研究。
Pharmacopsychiatry. 1996 Mar;29(2):63-6. doi: 10.1055/s-2007-979546.
9
Effect of NE-100, a novel sigma receptor ligand, on phencyclidine- induced delayed cognitive dysfunction in rats.
Neurosci Lett. 1995 Apr 7;189(1):60-2. doi: 10.1016/0304-3940(95)11440-8.
10
Naloxone-inaccessible sigma receptor in rat central nervous system.大鼠中枢神经系统中对纳洛酮不敏感的σ受体
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6703-7. doi: 10.1073/pnas.80.21.6703.

1型西格玛受体基因与精神分裂症之间无关联:病例对照研究的分析与荟萃分析结果

No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies.

作者信息

Uchida Naohiko, Ujike Hiroshi, Nakata Kenji, Takaki Manabu, Nomura Akira, Katsu Takeshi, Tanaka Yuji, Imamura Takaki, Sakai Ayumu, Kuroda Shigetoshi

机构信息

Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry, Shikata-cho 2-5-1, Okayama, 700-8558, Japan.

出版信息

BMC Psychiatry. 2003 Oct 21;3:13. doi: 10.1186/1471-244X-3-13.

DOI:10.1186/1471-244X-3-13
PMID:14567761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC270036/
Abstract

BACKGROUND

Several lines of evidence have supported possible roles of the sigma receptors in the etiology of schizophrenia and mechanisms of antipsychotic efficacy. An association study provided genetic evidence that the sigma receptor type 1 gene (SIGMAR1) was a possible susceptibility factor for schizophrenia, however, it was not replicated by a subsequent study. It is necessary to evaluate further the possibility that the SIGMAR1 gene is associated with susceptibility to schizophrenia.

METHODS

A case-control association study between two polymorphisms of the SIGMAR1 gene, G-241T/C-240T and Gln2Pro, and schizophrenia in Japanese population, and meta-analysis including present and previous studies.

RESULTS

There was no significant association of any allele or genotype of the polymorphisms with schizophrenia. Neither significant association was observed with hebephrenic or paranoid subtype of schizophrenia. Furthermore, a meta-analysis including the present and previous studies comprising 779 controls and 636 schizophrenics also revealed no significant association between the SIGMAR1 gene and schizophrenia.

CONCLUSION

In view of this evidence, it is likely that the SIGMAR1 gene does not confer susceptibility to schizophrenia.

摘要

背景

有几条证据支持西格玛受体在精神分裂症病因学及抗精神病药物疗效机制中可能发挥的作用。一项关联研究提供了基因证据,表明1型西格玛受体基因(SIGMAR1)可能是精神分裂症的一个易感因素,然而,随后的一项研究并未重复这一结果。有必要进一步评估SIGMAR1基因与精神分裂症易感性相关的可能性。

方法

在日本人群中开展一项病例对照关联研究,研究SIGMAR1基因的两个多态性位点G-241T/C-240T和Gln2Pro与精神分裂症之间的关系,并对本研究及之前的研究进行荟萃分析。

结果

这些多态性位点的任何等位基因或基因型与精神分裂症均无显著关联。在精神分裂症的青春型或偏执型亚型中也未观察到显著关联。此外,一项纳入本研究及之前研究(包括779名对照和636名精神分裂症患者)的荟萃分析也显示,SIGMAR1基因与精神分裂症之间无显著关联。

结论

鉴于这些证据,SIGMAR1基因可能不会导致精神分裂症易感性。